IGMS
Price
$1.40
Change
-$0.00 (-0.00%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
82.49M
13 days until earnings call
SONN
Price
$1.37
Change
-$0.05 (-3.52%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
4.17M
Ad is loading...

IGMS vs SONN

Header iconIGMS vs SONN Comparison
Open Charts IGMS vs SONNBanner chart's image
IGM Biosciences
Price$1.40
Change-$0.00 (-0.00%)
Volume$4.52K
Capitalization82.49M
Sonnet BioTherapeutics Holdings
Price$1.37
Change-$0.05 (-3.52%)
Volume$501
Capitalization4.17M
IGMS vs SONN Comparison Chart
Loading...
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IGMS vs. SONN commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IGMS is a Hold and SONN is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (IGMS: $1.38 vs. SONN: $1.36)
Brand notoriety: IGMS and SONN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IGMS: 76% vs. SONN: 66%
Market capitalization -- IGMS: $82.49M vs. SONN: $4.17M
IGMS [@Biotechnology] is valued at $82.49M. SONN’s [@Biotechnology] market capitalization is $4.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IGMS’s FA Score shows that 0 FA rating(s) are green whileSONN’s FA Score has 1 green FA rating(s).

  • IGMS’s FA Score: 0 green, 5 red.
  • SONN’s FA Score: 1 green, 4 red.
According to our system of comparison, IGMS is a better buy in the long-term than SONN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IGMS’s TA Score shows that 3 TA indicator(s) are bullish while SONN’s TA Score has 5 bullish TA indicator(s).

  • IGMS’s TA Score: 3 bullish, 5 bearish.
  • SONN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SONN is a better buy in the short-term than IGMS.

Price Growth

IGMS (@Biotechnology) experienced а +13.11% price change this week, while SONN (@Biotechnology) price change was +7.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

IGMS is expected to report earnings on Aug 11, 2025.

SONN is expected to report earnings on Nov 29, 2023.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IGMS($82.5M) has a higher market cap than SONN($4.17M). SONN YTD gains are higher at: -6.849 vs. IGMS (-77.414). SONN has higher annual earnings (EBITDA): -13.33M vs. IGMS (-199.47M). IGMS has more cash in the bank: 184M vs. SONN (4.86M). SONN has less debt than IGMS: SONN (111K) vs IGMS (45.2M). IGMS has higher revenues than SONN: IGMS (2.68M) vs SONN (1M).
IGMSSONNIGMS / SONN
Capitalization82.5M4.17M1,979%
EBITDA-199.47M-13.33M1,496%
Gain YTD-77.414-6.8491,130%
P/E RatioN/A0.29-
Revenue2.68M1M268%
Total Cash184M4.86M3,784%
Total Debt45.2M111K40,721%
FUNDAMENTALS RATINGS
SONN: Fundamental Ratings
SONN
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IGMSSONN
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 17 days ago
90%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SIGA6.480.24
+3.85%
SIGA Technologies
ALLY33.191.13
+3.52%
Ally Financial
CMBM0.400.01
+2.41%
Cambium Networks Corp
LEG7.420.11
+1.50%
Leggett & Platt
UCAR2.48-0.12
-4.62%
U Power Limited

IGMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGMS has been loosely correlated with INZY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if IGMS jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGMS
1D Price
Change %
IGMS100%
-0.72%
INZY - IGMS
53%
Loosely correlated
-2.10%
MRSN - IGMS
51%
Loosely correlated
-7.10%
CRNX - IGMS
47%
Loosely correlated
+3.15%
DYN - IGMS
45%
Loosely correlated
+3.06%
NTLA - IGMS
43%
Loosely correlated
+1.11%
More

SONN and

Correlation & Price change

A.I.dvisor tells us that SONN and VANI have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SONN and VANI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SONN
1D Price
Change %
SONN100%
-4.23%
VANI - SONN
27%
Poorly correlated
N/A
ABSI - SONN
27%
Poorly correlated
+0.94%
DWTX - SONN
27%
Poorly correlated
-3.58%
PRME - SONN
26%
Poorly correlated
-1.69%
IGMS - SONN
26%
Poorly correlated
-0.72%
More